EUVIMEDEUVIMED entdecken
Kommentar

Can MQ232 guide to novel options for treatment of ADPKD?

Enno Klussmann

Kidney International · 2026

DOI: 10.1016/j.kint.2026.06.020 ↗

Kurz gefasst

Kommentar in der Zeitschrift Kidney International, 2026. Verfasst von Enno Klussmann. Beteiligte Einrichtung: Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany; DZHK (German Center for Cardiovascular Research), par…. Hauptthemen laut MEDLINE: Polycystic Kidney, Autosomal Dominant. Die Arbeit nennt 9 Literaturangaben. Gefördert von: Bundesministerium fur Forschung Technologie und Raumfahrt Informationstechnikzentrum Bund, Else Kroner-Fresenius-Stiftung, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Wang et al. showcase a green mamba-derived compound, MQ232, which interferes with cyst growth in a mouse model of autosomal dominant polycystic kidney disease, similar to the only approved drug for autosomal dominant polycystic kidney disease treatment, tolvaptan. However, the authors reveal cyclic adenosine monophosphate-dependent and -independent components in MQ232's mode of action and gender differences in efficacy. Therefore, MQ232 may pave the way to novel treatment options for autosomal dominant polycystic kidney disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Kidney, Autosomal DominantAnimalsHumansMiceDisease Models, AnimalCyclic AMPTolvaptan

Substanzen

Cyclic AMPTolvaptan

Autor:innen und Institutionen

  • Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany; DZHK (German Center for Cardiovascular Research), partner site Berlin, Germany. Electronic address: enno.klussmann@mdc-berl…

Förderung

  • Bundesministerium fur Forschung Technologie und Raumfahrt Informationstechnikzentrum Bund
  • Else Kroner-Fresenius-Stiftung
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Klussmann, E. (2026). Can MQ232 guide to novel options for treatment of ADPKD?. Kidney International. https://doi.org/10.1016/j.kint.2026.06.020

Vancouver

Klussmann E. Can MQ232 guide to novel options for treatment of ADPKD?. Kidney International. 2026. doi:10.1016/j.kint.2026.06.020

BibTeX
@article{Klussmann2026,
  author = {Klussmann, Enno},
  title = {Can MQ232 guide to novel options for treatment of ADPKD?},
  journal = {Kidney International},
  year = {2026},
  doi = {10.1016/j.kint.2026.06.020}
}
Kostenlos starten →